Autobio Diagnostics and Subsidiary Secure Four Medical Device Registrations

Stock News
May 19

Autobio Diagnostics Co.,Ltd. (603658.SH) has announced that the company and its wholly-owned subsidiary, Autobio Instruments (Zhengzhou) Co., Ltd., recently received medical device registration certificates issued by the National Medical Products Administration and the Henan Provincial Medical Products Administration. A total of four products have obtained these registrations. They are: the fully automated chemiluminescence immunoassay analyzer (models: AutoLumo A6900, AutoLumo A9000, AutoLumo A9600), the Epstein-Barr virus capsid antigen IgM antibody detection kit (magnetic particle chemiluminescence method), the Mycoplasma pneumoniae nucleic acid and drug-resistant mutation site detection kit (PCR-fluorescence probe method), and the Interleukin-17A detection kit (magnetic particle chemiluminescence method).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10